NEW YORK (GenomeWeb) — NanoView Biosciences said today that it has closed a $10 million Series B round of financing.

The round was led by Northpond Ventures and included existing investors Sands Capital Ventures and PBM Capital Group.

Boston-based NanoView said it will use the funding to complete development of its ExoView system for the characterization of exosomes and other extracellular vesicles, as well as prepare for the product's commercial launch in early 2019.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.